|
Role of NFxB/HIF2a axis in renal cell carcinoma progression
|
1K08CA178168-01
|
$175,163
|
Abel, E
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-11
|
$24,894,951
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-10
|
$13,680
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Participation in the Eastern Cooperative Oncology Group
|
7U10CA107868-11
|
$160,010
|
AISNER, JOSEPH
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$708,251
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-11
|
$5,797,460
|
ANDERSON, JAMES
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
PHOTOACOUSTIC MICROSCOPY OF NEOVASCULARIZATION IN RENAL CANCER GROWTH AND THERAPY
|
5R01CA159959-03
|
$558,103
|
Arbeit, Jeffrey
|
WASHINGTON UNIVERSITY
|
|
Identifying a Hypoxia Inducible Factor target profile in Renal Cell Carcinoma tum
|
5F31CA154080-03
|
$34,547
|
Arreola, Alexandra
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-27
|
$1,874,946
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group Studies
|
3U10CA014548-38S1
|
$334,918
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
San Juan Minority-Based Community Clinical Oncology Program
|
2U10CA052667-23
|
$573,647
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
Discovery of Molecular and Imaging Biomarkers in RCC patient-Derived Tumorgrafts
|
5F31CA159897-03
|
$34,547
|
Bailey, Sean
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-16
|
$320,126
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$85,879
|
Bates, Susan
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$128,818
|
Bates, Susan
|
CCR (NCI)
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-29
|
$1,065,000
|
Bearden, James
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Iowa Oncology Research Association
|
5U10CA035101-28
|
$747,553
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
ECOG Clinical Trials
|
5U10CA017145-38
|
$362,638
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA006516-48S1
|
$114,538
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-48S3
|
$12,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-48S4
|
$50,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-48
|
$10,435,722
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
5U10CA063844-20
|
$736,823
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Eastern Cooperative Oncology Group
|
5U10CA049957-25
|
$291,047
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MED CTR
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-28S1
|
$362,418
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-32
|
$9,816,255
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-29
|
$2,684,982
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$224,699
|
Beutler, John
|
CCR (NCI)
|
|
Mechanism of Acquired Resistance to VEGF-R Antagonists in RCC
|
5K08CA138900-04
|
$169,560
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
JHU ICMIC Program
|
5P50CA103175-08
|
$1,519,395
|
Bhujwalla, Zaver
|
JOHNS HOPKINS UNIVERSITY
|
|
Identifying rare haplotype-environment interactions using Logistic Bayesian Lasso
|
5R03CA171011-03
|
$82,326
|
Biswas, Swati
|
UNIVERSITY OF TEXAS DALLAS
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-34S1
|
$429,287
|
BLANKE, CHARLES
|
UNIVERSITY OF MICHIGAN
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-34
|
$12,219,352
|
BLANKE, CHARLES
|
UNIVERSITY OF MICHIGAN
|
|
Southwest Oncology Group Biorepository
|
5U24CA114748-08
|
$1,057,961
|
BLANKE, CHARLES
|
UNIVERSITY OF MICHIGAN
|
|
SWOG Community Clinical Oncology Program Research Base
|
7U10CA037429-29
|
$4,229,363
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-16
|
$447,372
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIA BC 011095
|
$132,612
|
Bottaro, Donald
|
CCR (NCI)
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIA BC 011123
|
$79,567
|
Bottaro, Donald
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$318,269
|
Bottaro, Donald
|
CCR (NCI)
|
|
Laboratory of Translational Genomics_Brown
|
ZIA CP010201-10570
|
$548,061
|
Brown, Kevin
|
DCEG (NCI)
|
|
Eastern Cooperative Oncology Group
|
3U10CA080775-14S1
|
$43,980
|
BUBLEY, GLENN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Cancer and Leukemia Group B
|
5U10CA032291-32
|
$454,439
|
Burstein, Harold
|
DANA-FARBER CANCER INST
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$1,048,784
|
Caporaso, Neil
|
DCEG (NCI)
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-14S1
|
$113,245
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-14S2
|
$71,639
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
5P30CA071789-14
|
$1,063,659
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Phase I Clinical Trials of New Anti-Cancer Targeted Therapies
|
3U01CA070095-18S1
|
$845,109
|
Carducci, Michael
|
JOHNS HOPKINS UNIVERSITY
|
|
Ozark Health Ventures, LLC dba Cancer Research for the Ozarks
|
5U10CA045560-25
|
$744,590
|
Carlson, Jay
|
OZARK HEALTH VENTURES, LLC
|
|
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
|
5U24CA160034-03
|
$3,019,843
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|